Goelzer Investment Management Has Decreased By $2.70 Million Its Pulte Group (PHM) Holding; Last Week Meridian Bioscience, Inc. (VIVO) Coverage

May 26, 2018 - By Darrin Black

Meridian Bioscience, Inc. (NASDAQ:VIVO) Logo

Among 5 analysts covering Meridian Bioscience (NASDAQ:VIVO), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Meridian Bioscience had 13 analyst reports since July 28, 2015 according to SRatingsIntel. Piper Jaffray maintained the shares of VIVO in report on Thursday, July 27 with “Sell” rating. The stock of Meridian Bioscience, Inc. (NASDAQ:VIVO) earned “Hold” rating by Robert W. Baird on Thursday, October 19. The firm has “Neutral” rating given on Monday, March 21 by Hilliard Lyons. The stock has “Sell” rating by Piper Jaffray on Thursday, January 25. The stock of Meridian Bioscience, Inc. (NASDAQ:VIVO) earned “Buy” rating by Hilliard Lyons on Monday, March 28. On Thursday, January 25 the stock rating was maintained by Canaccord Genuity with “Hold”. On Thursday, January 25 the stock rating was maintained by Robert W. Baird with “Hold”. The stock of Meridian Bioscience, Inc. (NASDAQ:VIVO) has “Sell” rating given on Thursday, October 19 by Piper Jaffray. The firm earned “Sell” rating on Thursday, September 21 by Piper Jaffray. As per Thursday, September 10, the company rating was maintained by Canaccord Genuity. See Meridian Bioscience, Inc. (NASDAQ:VIVO) latest ratings:

25/01/2018 Broker: Piper Jaffray Rating: Sell New Target: $11.0 Maintain
25/01/2018 Broker: Canaccord Genuity Rating: Hold New Target: $16.0 Maintain
25/01/2018 Broker: Robert W. Baird Rating: Hold New Target: $16.0 Maintain

Goelzer Investment Management Inc decreased Pulte Group Inc (PHM) stake by 19.18% reported in 2017Q4 SEC filing. Goelzer Investment Management Inc sold 81,878 shares as Pulte Group Inc (PHM)’s stock declined 12.41%. The Goelzer Investment Management Inc holds 344,905 shares with $11.47M value, down from 426,783 last quarter. Pulte Group Inc now has $8.70 billion valuation. The stock increased 1.16% or $0.35 during the last trading session, reaching $30.47. About 2.93M shares traded. PulteGroup, Inc. (NYSE:PHM) has risen 24.54% since May 26, 2017 and is uptrending. It has outperformed by 12.99% the S&P500.

The stock increased 1.02% or $0.15 during the last trading session, reaching $14.8. About 152,993 shares traded. Meridian Bioscience, Inc. (NASDAQ:VIVO) has risen 7.87% since May 26, 2017 and is uptrending. It has underperformed by 3.68% the S&P500.

Since February 7, 2018, it had 2 buys, and 0 insider sales for $28,784 activity. On Wednesday, February 7 Rice John McCune Jr. bought $14,750 worth of Meridian Bioscience, Inc. (NASDAQ:VIVO) or 1,000 shares. $14,034 worth of Meridian Bioscience, Inc. (NASDAQ:VIVO) was bought by McIlwraith John on Friday, February 23.

Meridian Bioscience, Inc., a life science company, develops, makes, distributes, and sells diagnostic test kits primarily for various gastrointestinal, viral, respiratory, and parasitic infectious diseases worldwide. The company has market cap of $626.70 million. The firm operates through Diagnostics and Life Science divisions. It has a 29.02 P/E ratio. The Diagnostics segment offers testing platforms and technologies, including isothermal DNA amplification under the illumigene brand; rapid immunoassays, a single-use immunoassays that can be used in point-of-care settings under the TRU, ImmunoCard, and ImmunoCard STAT! brand names; enzyme-linked immunoassays under the Premier brand; and anodic stripping voltammetry, an electrical chemical sensor platform for quantitative determination under the LeadCare brand.

Investors sentiment decreased to 1.2 in 2017 Q4. Its down 0.17, from 1.37 in 2017Q3. It worsened, as 21 investors sold Meridian Bioscience, Inc. shares while 44 reduced holdings. 31 funds opened positions while 47 raised stakes. 36.52 million shares or 0.72% more from 36.26 million shares in 2017Q3 were reported. Bessemer Group has invested 0% in Meridian Bioscience, Inc. (NASDAQ:VIVO). Hotchkis Wiley Capital Limited Liability Corp holds 0% of its portfolio in Meridian Bioscience, Inc. (NASDAQ:VIVO) for 27,205 shares. Royal Natl Bank Of Canada holds 0% in Meridian Bioscience, Inc. (NASDAQ:VIVO) or 47,417 shares. 36,570 are held by Ronna Sue Cohen. Prudential Fincl stated it has 0.01% of its portfolio in Meridian Bioscience, Inc. (NASDAQ:VIVO). Alliancebernstein Ltd Partnership owns 79,337 shares or 0% of their US portfolio. Northern Corp holds 0% or 545,956 shares. Park Corporation Oh holds 0.01% or 10,450 shares in its portfolio. Metropolitan Life Com New York has 14,301 shares. Dimensional Fund Advsrs Ltd Partnership holds 1.79M shares. Spark Investment Mgmt Limited Liability Company, a New York-based fund reported 206,500 shares. 48,970 were accumulated by Brinker. Parallax Volatility Advisers L P, California-based fund reported 6,384 shares. Assetmark holds 62 shares or 0% of its portfolio. Texas Permanent School Fund holds 0% or 28,528 shares.

Another recent and important PulteGroup, Inc. (NYSE:PHM) news was published by Seekingalpha.com which published an article titled: “PulteGroup Does It Again” on April 27, 2018.

Since December 8, 2017, it had 1 buying transaction, and 5 sales for $5.40 million activity. On Thursday, May 10 Hawaux Andre J bought $97,061 worth of PulteGroup, Inc. (NYSE:PHM) or 3,100 shares. OLEARY PATRICK J sold $260,607 worth of PulteGroup, Inc. (NYSE:PHM) on Wednesday, February 21. $1.62M worth of PulteGroup, Inc. (NYSE:PHM) shares were sold by SMITH HARMON D. $3.15M worth of PulteGroup, Inc. (NYSE:PHM) was sold by OShaughnessy Robert on Friday, December 8. GRISE CHERYL W had sold 14,000 shares worth $430,384 on Wednesday, May 2.

Investors sentiment increased to 1.01 in 2017 Q4. Its up 0.25, from 0.76 in 2017Q3. It improved, as 30 investors sold PHM shares while 182 reduced holdings. 86 funds opened positions while 128 raised stakes. 236.87 million shares or 3.30% less from 244.94 million shares in 2017Q3 were reported. Tocqueville Asset Mgmt Ltd Partnership holds 10,120 shares or 0% of its portfolio. Oppenheimer Asset Mgmt owns 23,475 shares for 0.02% of their portfolio. Thompson Invest Management Incorporated has invested 0.09% in PulteGroup, Inc. (NYSE:PHM). Fmr Lc holds 0.02% or 4.84 million shares in its portfolio. Swiss Fincl Bank invested in 0.04% or 1.00M shares. Pacad Investment Ltd holds 0.33% of its portfolio in PulteGroup, Inc. (NYSE:PHM) for 43,700 shares. Winslow Evans And Crocker Inc has invested 0.11% of its portfolio in PulteGroup, Inc. (NYSE:PHM). Campbell & Invest Adviser Lc holds 0.23% or 9,316 shares in its portfolio. Rmb Capital Mgmt Limited Co reported 17,000 shares. Nuveen Asset Lc invested in 0% or 6,553 shares. Riverhead Cap Mgmt Ltd has 0.1% invested in PulteGroup, Inc. (NYSE:PHM). Smith Salley And Assoc has 22,500 shares. First Republic Inv Mngmt Incorporated stated it has 0% in PulteGroup, Inc. (NYSE:PHM). Nordea Invest Mgmt Ab has 0% invested in PulteGroup, Inc. (NYSE:PHM) for 12,777 shares. Neuberger Berman owns 558,478 shares.

Goelzer Investment Management Inc increased Ishares Tr (ACWX) stake by 37,241 shares to 1.12M valued at $55.71 million in 2017Q4. It also upped Vanguard Index Fds (VNQ) stake by 21,626 shares and now owns 106,095 shares. Pepsico Inc (NYSE:PEP) was raised too.

Among 22 analysts covering PulteGroup (NYSE:PHM), 11 have Buy rating, 2 Sell and 9 Hold. Therefore 50% are positive. PulteGroup had 76 analyst reports since September 11, 2015 according to SRatingsIntel. RBC Capital Markets maintained the shares of PHM in report on Wednesday, October 25 with “Outperform” rating. The firm earned “Overweight” rating on Thursday, April 26 by JP Morgan. The stock has “Neutral” rating by B. Riley & Co on Wednesday, January 3. On Thursday, July 13 the stock rating was upgraded by Wedbush to “Neutral”. Raymond James downgraded the stock to “Market Perform” rating in Monday, April 25 report. FBR Capital downgraded it to “Hold” rating and $36.0 target in Wednesday, January 3 report. The stock of PulteGroup, Inc. (NYSE:PHM) has “Buy” rating given on Tuesday, November 14 by RBC Capital Markets. UBS maintained PulteGroup, Inc. (NYSE:PHM) on Wednesday, January 17 with “Buy” rating. The stock of PulteGroup, Inc. (NYSE:PHM) has “Outperform” rating given on Friday, January 27 by RBC Capital Markets. The rating was downgraded by Mizuho to “Underperform” on Monday, July 10.

Analysts await PulteGroup, Inc. (NYSE:PHM) to report earnings on July, 24. They expect $0.74 EPS, up 57.45% or $0.27 from last year’s $0.47 per share. PHM’s profit will be $211.29 million for 10.29 P/E if the $0.74 EPS becomes a reality. After $0.59 actual EPS reported by PulteGroup, Inc. for the previous quarter, Wall Street now forecasts 25.42% EPS growth.

PulteGroup, Inc. (NYSE:PHM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>